AstraZeneca to withdraw sales of Covid-19 vaccine globally

1 week ago 9

1 min read 08 May 2024, 06:33 AM IST

AstraZeneca withdraws Covid-19 vaccine globally owed to surplus of updated vaccines. Admitted vaccine tin origin humor clot side-effect successful precise uncommon cases

AstraZeneca to halt income of Covid-19 vaccine (REUTERS)

AstraZeneca has initiated the worldwide withdrawal of its Covid-19 vaccine owed to a "surplus of disposable updated vaccines" since the pandemic. Recently, UK-headquartered pharmaceutical elephantine admitted that successful "very uncommon cases", its Covid vaccine tin origin a humor clot-related side-effect but the causal nexus is unknown.

The Daily Telegraph reported that successful a ineligible papers submitted to the High Court successful London successful February for a radical enactment brought by 51 claimants, AstraZeneca admitted that the vaccine developed with the University of Oxford to support against Covid-19 whitethorn origin Thrombosis with Thrombocytopenia Syndrome (TTS) successful "very uncommon cases".

The AstraZeneca Vaxzevria vaccine, besides manufactured by the Serum Institute of India, was marketed successful India arsenic Covishield.

Unlock a satellite of Benefits! From insightful newsletters to real-time banal tracking, breaking quality and a personalized newsfeed - it's each here, conscionable a click away! Login Now!

Catch each the Corporate news and Updates connected Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.

More Less

Published: 08 May 2024, 06:33 AM IST